TNDM
Tandem Diabetes Care Inc
NASDAQ: TNDM · HEALTHCARE · MEDICAL DEVICES
$16.65
+1.22% today
Updated 2026-10-13
Market cap
$1.22B
P/E ratio
—
P/S ratio
1.17x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$11 – $30
Volume
2.1M
Tandem Diabetes Care Inc (TNDM) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.65
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.7B | $0.8B | $0.7B | $0.9B | $1.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -6.08%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.